Concepedia

Steven K. Albanese

SK

Statistics

Publications

15

Citations

1.2K

H-Index

14

Active since

2016

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Schrodinger (United States)

Cornell University

Tri-Institutional PhD Program in Chemical Biology

Steven K. Albanese is an author at Memorial Sloan Kettering Cancer Center specializing in molecular biology, drug discovery, and life sciences.

Publications per year

2016–2024

15

Publications

15

Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations

Andrew M. Intlekofer, Alan H. Shih, Bo Wang et al. · Nature · 2018 · 280 citations · Full text

Life Sciences, Genetics, Molecular Biology +13

The maximal and current accuracy of rigorous protein-ligand binding free energy calculations

Gregory A. Ross, Chao Lü, Guido Scarabelli et al. · Communications Chemistry · 2023 · 150 citations · Full text

Pharmacy, Medicinal Chemistry, Computational Chemistry +14

Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia

Gerard Minuesa, Steven K. Albanese, Wei Xie et al. · Nature Communications · 2019 · 146 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Predicting resistance of clinical Abl mutations to targeted kinase inhibitors using alchemical free-energy calculations

Kevin Hauser, Christopher Negron, Steven K. Albanese et al. · Communications Biology · 2018 · 102 citations · Full text

Medicine, Oncology, Pharmacology +14

Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin

Jianing Xu, Can G. Pham, Steven K. Albanese et al. · Journal of Clinical Investigation · 2016 · 95 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 15